Thrombolysis in elderly people: Observational data insufficient to change treatment

BMJ

Volumn 342, Issue 7790, 2011, Pages 185-

  Lindley, Richard I ^a   Wardlaw, Joanna M ^b   Sandercock, Peter A G ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); ELDERLY CARE; FIBRINOLYTIC THERAPY; HUMAN; LETTER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; STROKE; TREATMENT PLANNING; AGE; AGED; NOTE;

AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; STROKE; THROMBOLYTIC THERAPY;

EID: 78751691090     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d306     Document Type: Letter

References (3)

1. Mishra NK, Ahmed N, Andersen G, Egido JA, Lindsberg PJ, Ringleb PA, et al, for the VISTA and SITS collaborators. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ 2010;341:c6046. (23 November.)
2. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischemic stroke. Stroke 2010; published online April 15. doi: 10.1161/STROKEAHA.109.575530.
3. Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S, et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 2010;41:1450-8.